DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

Issue 07 · Volume 58 · 1987 DOI: 10.1055/s-009-45132

Review Article

  • 801
    Hanson, Stephen R; Harker, Laurence A:

    Baboon Models of Acute Arterial Thrombosis

    • Original Article

  • 806
    Thompson, E Anne; Salem, Hatem H:

    The Effects of Human Thrombomodulin on the Inactivation of Thrombin by Its Serum Inhibitors

  • 811
    Wessels, P; Heyns, A du P; Esterhuysen, A J; Badenhorst, P N; Lötter, M G; Pieters, H; Kotzè, H F:

    Kinetics and In Vivo Distribution of In-111-Labelled Platelets and Platelet Function in Familial Hypercholesterolaemia

  • 817
    Gram, Jørgen; Kluft, Cornelis; Jespersen, Jørgen:

    Depression of Tissue Plasminogen Activator (t-PA) Activity and Rise of t-PA Inhibition and Acute Phase Reactants in Blood of Patients with Acute Myocardial Infarction (AMI)

  • 822
    Larsson, G; Larsson, Å; Åstedt, B:

    Tissue Plasminogen Activator and Urokinase in Normal, Dysplastic and Cancerous Squamous Epithelium of the Uterine Cervix

  • 827
    Korbut, R; Dembińska-Kieć, A; Świȩs, J; Źmuda, A; Gryglewski, R J:

    On the Mechanism of Thrombolytic Action of Thromboxane Synthetase Inhibitors

  • 831
    Christensen, S Winter; Wille-Jørgensen, P; Kjær, L; Stadeager, C; Widding, A; Vestergaard, Aa; Bjerg-Nielsen, A:

    Contact Thermography, 99mTc-Plasmin Scintimetry and 99mTc-Plasmin Scintigraphy as Screening Methods for Deep Venous Thrombosis Following Major Hip Surgery

  • 834
    Lande, Knut; Kjeldsen, Sverre Erik; Eide, Ivar; Leren, Paul; Gjesdal, Knut:

    Does Increased Platelet Release Normalize During Anti-Hypertensive Treatment?

  • 839
    Merton, R E; Thomas, D P:

    Experimental Studies on the Relative Efficacy of Dermatan Sulphate and Heparin as Antithrombotic Agents

  • 843
    Anglés-Cano, E; Boutière, B; Arnoux, D; Masson, C; Contant, G; Benchimol, P; Sampol, J:

    Release Pattern of the Vascular Plasminogen Activator and Its Inbibitor in Human Postvenous Occlusion Plasma as Assessed by a Spectrophotometric Solid-Phase Fibrin-tPA Activity Assay

  • 850
    McCrohan, M B; Huang, S W; Sleasman, J W; Klein, P A; Kao, K J:

    Plasma Thrombospondin as an Indicator of Intravascular Platelet Activation in Patients with Vasculitis

  • 853
    Fey, Martin F; Lang, Mathis; Furlan, Miha; Beck, Eugen A:

    Monitoring of Heparin Therapy with the Activated Partial Thromboplastin Time and Chromogenic Substrate Assays

  • 856
    Dati, F; Barthels, M; Conard, J; Flückiger, J; Girolami, A; Hänseler, E; Huber, J; Keller, F; Kolde, H -J; Müller-Berghaus, G; Samama, M; Thiel, W:

    Multicenter Evaluation of a Chromogenic Substrate Method for Photometric Determination of Prothrombin Time

  • 866
    Santoso, S; Kiefel, V; Mueller-Eckhardt, C:

    Redistribution of Platelet Glycoproteins Induced by Allo- and Autoantibodies

  • 872
    Jørgensen, Maja; Philips, Malou; Thorsen, Sixtus; Selmer, Johan; Zeuthen, Jesper:

    Plasminogen Activator Inhibitor-1 Is the Primary Inhibitor of Tissue-Type Plasminogen Activator in Pregnancy Plasma

  • 879
    Sié, P; Aillaud, M F; Prost, D de; Droullé, C; Forestier, F; Guedj, P; Juhan-Vague, I; Polack, B; Potron, G; Roncato, M; Roussi, J; Sampol, J; Aiach, M:

    Measurement of Low Molecular Weight Heparin Ex Vivo Activities in Clinical Laboratories Using Various Anti-Xa Assays: Interlaboratory Variability and Requirement for an Agreed Low Molecular Weight Heparin Standard

  • 884
    Lyon, Sandra G; Lasser, Elliott C; Stein, Rosalyn:

    Modification of an Amidolytic Heparin Assay to Express Protein-Bound Heparin and to Correct for the Effect of Antithrombin III Concentration

  • 888
    Wolf, M; Boyer-Neumann, C; Meyer, D; Tripodi, A; Mannucci, P M; Larrieu, M J:

    Purification and Further Characterization of Antithrombin III Milano: Lack of Reactivity with Thrombin

  • 893
    Bergqvist, David; Nilsson, Bodil:

    The Influence of Low Molecular Weight Heparin in Combination with Dihydroergotamine on Experimental Thrombosis and Haemostasis

  • 896
    Ghirardini, A; Mariani, G; lacopino, G; Tirindelli, M C; Solinas, S; Moretti, T:

    Concentrated DDAVP: Further Improvement in the Management of Mild Factor VIII Deficiencies

  • 899
    Bauman, Joan E; Joachim Reimers, H; Heinrich Joist, J:

    Deaggregation of In Vitro-Degranulated Human Platelets: Irreversibility of Aggregation May Be Agonist-Specific Rather Than Related to Secretion Per Se

  • 905
    Palareti, G; Coccheri, S; Poggi, M; Bonetti, M; Cervi, V; Mazzuca, A; Savoia, M; Veri, L; Fiori, F; Gaspari, G; Palareti, A; The Bologna oral anticoagulant control study group:

    Oral Anticoagulant Therapy Control: Evidence that INR Expression Improves the Inter-Laboratory Comparability of Results - The Bologna Oral Anticoagulant Control Exercise

  • 911
    Parker, R I; Shafer, Brenda C; Gralnick, H R:

    Platelet Density-Dependent Partition of Platelet- von Willebrand Factor Between Alpha Granule and Non-Alpha Granule Pools

  • 915
    Jandrot-Perrus, Martine; Guillin, Marie-Claude; Nurden, Alan T:

    Human Gamma-Thrombin: Lack of Correlation Between a Platelet Functional Response and Glycoprotein V Hydrolysis

  • 921
    Seifried, E; Tanswell, P:

    Comparison of Specific Antibody, D-Phe-Pro-Arg-CH2Cl and Aprotinin for Prevention of In Vitro Effects of Recombinant Tissue-Type Plasminogen Activator on Haemostasis Parameters

  • 927
    de Chaffoy de Courcelles, D; Roevens, P; Verheyen, F; Van Belle, H; De Clerck, F:

    The Effect of the Intracellular Calcium Chelator Quin-2 on the Platelet Phosphoinositide Metabolism, Protein Phosphorylation and Morphology

  • 932
    Palm, M; Mattsson, Ch:

    Pharmacokinetics of Heparin and Low Molecular Weight Heparin Fragment (Fragmin®) in Rabbits with Impaired Renal or Metabolic Clearance

  • 936
    Miles, Lindsey A; Plow, Edward F:

    Receptor Mediated Binding of the Fibrinolytic Components, Plasminogen and Urokinase, to Peripheral Blood Cells

  • 943
    Collen, D; Stassen, J M; De Cock, F:

    Synergistic Effect on Thrombolysis of Sequential Infusion of Tissue-Type Plasminogen Activator (t-PA) Single-Chain Urokinase-Type Plasminogen Activator (scu-PA) and Urokinase in the Rabbit Jugular Vein Thrombosis Model

  • 947
    Stassen, J M; Juhan-Vague, I; Alessi, M C; De Cock, F; Collen, D:

    Potentiation by Heparin Fragments of Thrombolysis Induced with Human Tissue-Type Plasminogen Activator or Human Single-Chain Urokinase-Type Plasminogen Activator